Indies Pharma Jamaica Limited (JMSE: INDIES)

Indies Pharma Jamaica Revenue

Indies Pharma Jamaica had revenue of 296.46M JMD in the quarter ending July 31, 2024, a decrease of -1.09%. This brings the company's revenue in the last twelve months to 1.14B, up 13.97% year-over-year. In the fiscal year ending October 31, 2023, Indies Pharma Jamaica had annual revenue of 1.06B with 12.61% growth.

• Revenue (ttm): 1.14B
• Revenue Growth: +13.97%
• P/S Ratio: 3.69
• Revenue / Employee: 16.00M
• Employees: 71
• Market Cap: 4.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2023	1.06B	118.18M	12.61%
Oct 31, 2022	937.28M	90.45M	10.68%
Oct 31, 2021	846.83M	80.88M	10.56%
Oct 31, 2020	765.95M	36.50M	5.00%
Oct 31, 2019	729.45M	93.28M	14.66%